in

[INTERVIEW] Be Very Concerned About Health Canada Changes to Natural Health Products -Dr. Byram Bridle

[INTERVIEW] Be Very Concerned About Health Canada Changes to Natural Health Products -Dr. Byram Bridle

Dr. Byram Bridle, Viral Immunologist & Vaccinologist, joins me to discuss Health Canada’s attack on natural health products (NHPs) stemming from its “massive” Pharma conflict of interest. He also drops a breaking story on McGill University’s unethical alliance with Moderna.

 

Just $2 helps us to continue creating awareness about the govt’s attack on NHPs. Even better, $2 per month. Please DONATE TODAY at or by etransfer to gord@brightlightnews.com. Thank you.

 

Health Canada states that natural health products need greater regulation to ensure safety.
While possession of up to 2.5 grams of deadly drugs, like fentanyl and cocaine, have been decriminalized by the BC govt, safe natural health products are undergoing tighter regulations.
Health Canada’s fee structure shows that Big Pharma pays $565,465 per new drug application.
Sections 500-504 of Bill C-47 (received Royal Assent June, 22, 2023) outline the inclusion of natural health products under the same regulations of synthetic drugs.

Dr. Byram Bridle announces evidence with the world that the Covid-19 shot contents did not stay in the shoulder, as promoted by govts, and instead were biodistributed systemically. Dr. Bridle’s career and reputation was destroyed shortly after this airing.
Just 5 days ago, McGill University announced a collaboration with Moderna to see, as Dr. Bridle said 2 years ago, investigate if the “vaccine” was distributed throughout the whole body.
How Bad Is My Batch shows adverse events rates within specific Covid-19 shot batches.

What do you think?

Written by colinnew

Leave a Reply

Your email address will not be published. Required fields are marked *

Who was Fernando Villavicencio, presidential hopeful shot dead in Ecuador?

Who was Fernando Villavicencio, presidential hopeful shot dead in Ecuador?

US Supreme Court halts Purdue Pharma bankruptcy settlement pending review

US Supreme Court halts Purdue Pharma bankruptcy settlement pending review